Canada markets close in 36 minutes

Kura Oncology, Inc. (KURA)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
30.42-0.13 (-0.43%)
As of 3:24PM EDT. Market open.
Currency in USD

Valuation Measures

Market Cap (intraday) 51.71B
Enterprise Value 31.4B
Trailing P/E N/A
Forward P/E 1-16.01
PEG Ratio (5 yr expected) 1-0.88
Price/Sales (ttm)N/A
Price/Book (mrq)5.30
Enterprise Value/Revenue 3N/A
Enterprise Value/EBITDA 6-17.90

Trading Information

Stock Price History

Beta (5Y Monthly) 2.43
52-Week Change 3100.85%
S&P500 52-Week Change 315.51%
52 Week High 331.28
52 Week Low 36.35
50-Day Moving Average 325.42
200-Day Moving Average 317.33

Share Statistics

Avg Vol (3 month) 3578.25k
Avg Vol (10 day) 3598.44k
Shares Outstanding 556.28M
Float 49.27M
% Held by Insiders 113.02%
% Held by Institutions 173.71%
Shares Short (Sep. 14, 2020) 43.87M
Short Ratio (Sep. 14, 2020) 44.89
Short % of Float (Sep. 14, 2020) 48.22%
Short % of Shares Outstanding (Sep. 14, 2020) 46.88%
Shares Short (prior month Aug. 13, 2020) 43.95M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec. 30, 2019
Most Recent Quarter (mrq)Jun. 29, 2020


Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-15.76%
Return on Equity (ttm)-26.00%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -77.99M
Net Income Avi to Common (ttm)-73.95M
Diluted EPS (ttm)-1.58
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)338.87M
Total Cash Per Share (mrq)6.02
Total Debt (mrq)15.26M
Total Debt/Equity (mrq)4.74
Current Ratio (mrq)18.45
Book Value Per Share (mrq)5.74

Cash Flow Statement

Operating Cash Flow (ttm)-60.63M
Levered Free Cash Flow (ttm)-36.27M